Hemostatic Agents Market is anticipated to hit $8.94 billion by 2023 at a CAGR of 7.10%.

According to the new market research report by IndustryARC titled “Hemostatic Agents Market: By Type (Thrombin, Oxidized Regenerated Cellulose, Combination, Gelatin, Collagen, Fibrin Sealants); By Treatment (Cardiovascular, General, Digestive, Neurological); By End User (Hospitals, Surgical Centers, Nursing Homes) & Geography – Forecast (2016-2022)”, the market is driven by the increase in surgical procedures across the globe coupled with the rise in the number of insurance providers propelling the Hemostats Market. Increase in hospital facilities with government initiatives is another reason driving the growth of the Hemostats Market.

Americas held the largest market share in the Hemostatic Agents Market

The American region holds the largest market share and growth in the Hemostatic agents Market and is anticipated to reach $4.7 billion by 2023 at a CAGR of 7.20%. However, APAC registers the highest growth and is anticipated to reach $1.6 billion at a CAGR of 11.4%. The American region is the dominant market for hemostats market due to its growing technological advancements, and need for enhancing the patient safety. The key end-users in this region include Hospitals, Surgery Centers, and Nursing Homes.

Selected Market Share Analysis done in the full report

  • As per IndustryARC analysts, manufacturers in Hemostats are estimated to take a leap in the production of these products owing to the increasing demand from the medical segment.

  • The market share analysis has been done considering the revenue of Hemostats suppliers. The market is fairly fragmented with small companies accounting for a combined share of 52% in terms of revenue.

  • Some big companies have significant presence in this market mainly due to their strong clientele in the commercial sector and strong manufacturing capability.

  • The suppliers of the market continue to evolve to meet the challenges of technology, growing consumer demands, increased emphasis on sustainable products, globalization, cost pressures, growing healthcare sector, increasing population and more.

  • Since the product in focus is constantly upgraded with new innovations, many small suppliers easily penetrate into the market. As a result of which, major suppliers have not been able to gain a stronghold in the market. However, monitoring their future business involvements, IndustryARC analysts anticipate companies such as Baxter, Pfizer, Braun, CSL Behring and more to maintain their position in the market.

To purchase or browse the table of contents of the report follow the link below:


Excerpts on Market Growth Factors

  • High requirement for spinal surgeries have resulted in an increased growth rate for hemostats in U.S. market.

  • Other growth factors include technological advancements alongside increasing hospitals and healthcare facilities, which ultimately resulted in adoption of advanced surgical equipment in surgeries.

  • The adoption rate of hemostats was attributed to the aging population, as this is an important procedure to prevent blood loss in the patients.

  • Amongst various end users, hospitals generated the highest revenue and is anticipated to reach $4.5 billion by 2022

  • Rising awareness about the advanced equipment among the public, increased spending in healthcare, growing use of artificial devices in operations is resulting in the growth of the hemostats market.

Talk to one of our sales representative about the full report by providing your details in the below link:


Key players of Hemostatic Agents Market:

  • Johnson & Johnson is one of the leading suppliers in the Hemostats market, contributing to nearly 17% of the overall revenue. Johnson & Johnson through its broad range of products, constant product launches and innovation have been successful in catering to a variety of customers, consequently maintaining their hold over the market.

  • However, monitoring their future business involvements, IndustryARC analysts anticipate companies such as Baxter, Pfizer, Braun, C.R. Bard, CSL Behring and more to maintain their position in the market.

  • Baxter International holds second major share in the Hemostats market.

  • Baxter International Incorporation, Mallinckrodt Plc, C.R. Brad Incorporation, Integra Life Sciences Corporation and others are the names of few companies involved in acquisition strategies.

Hemostatic Agents Market Report is segmented as indicated below

  • Hemostatic Agents Market By Type:

    1. Thrombin Based Hemostats

    2. Gelatin Based Hemostats

    3. Collagen Based Hemostats

    4. Oxidized Based Hemostats

    5. Combination Hemostats

    6. Fibrin Hemostats

    7. Others

  • Hemostatic Agents Market By Treatment

  1. Cardiovascular

  2. General Surgery

  3. Digestive Surgery

  4. Neurosurgery

  5. Others

  • Hemostatic Agents Market By End User

  1. Hospitals

  2. Surgery Centers

  3. Nursing Homes

  4. Others

  • Hemostatic Agents Market By Geography (Covers 13 + Countries)

  • Hemostatic Agents Market By Entropy

Companies Cited/Referenced/Interviewed:

  1. B. Braun Melsungen

  2. Integra Life Sciences Corporation

  3. Equimedical B.V.

  4. Marine Polymer Technologies Inc.

  5. Gelita GmBh

  6. Johnson and Johnson Services

  7. Pfizer Inc;

  8. Advanced Medical Solutions Group (Resorba Wundversorgung)

  9. Vascular Solutions Inc;

  10. Z-Medica LLC

  11. Mallinckrodt PLC

  12. Company 12

  13. Company 13

  14. Company 14

  15. Company 15+

Related Reports

  1. Hemodynamic Monitoring System Market


  1. Blood Culture Tests Market


What can you expect from the report?

The Hemostatic Agents Market is Prepared with the Main Agenda to Cover the following 20 points:

  1. Market Size by Product Categories

  2. Market trends

  3. Manufacturer Landscape

  4. Distributor Landscape

  5. Pricing Analysis

  6. Top 10 End user Analysis

  7. Product Benchmarking

  8. Product Developments

  9. Mergers & Acquisition Analysis

  10. Patent Analysis

  11. Demand Analysis (By Revenue & Volume)

  12. Country level Analysis (15+)

  13. Competitor Analysis

  14. Market Shares Analysis

  15. Value Chain Analysis

  16. Supply Chain Analysis

  17. Strategic Analysis

  18. Current & Future Market Landscape Analysis

  19. Opportunity Analysis

  20. Revenue and Volume Analysis


Does IndustryARC publish country, geography or application based reports in Hemostatic Agents Market?

Yes, we do have separate reports as mentioned below:

    1. Americas Market for Hemostatic Agents (2018-2023)

    2. Europe Market for Hemostatic Agents(2018-2023)

    3. APAC Market for Hemostatic Agents(2018-2023)

    4. RoW Market for Hemostatic Agents(2018-2023)

    5. Hospitals Market for Hemostatic Agents (2018-2023)

    6. Surgery Centres Market for Hemostatic Agents (2018-2023)

    7. Nursing Homes Market for Hemostatic Agents (2018-2023)

    8. Cardiovascular Market for Hemostatic Agents (2018-2023)

    9. General Surgery Market for Hemostatic Agents (2018-2023)

    10. Digestive Surgery Market for Hemostatic Agents (2018-2023)

    11. Neurosurgery Market for Hemostatic Agents (2018-2023)

    12. Thrombin based Hemostats Market for Hemostatic Agents (2018-2023)

    13. Gelatin based Hemostats Market for Hemostatic Agents (2018-2023)

    14. Collagen based Hemostats Market for Hemostatic Agents (2018-2023)

    15. Oxidized Regenerated Cellulose Based Hemostats Market for Hemostatic Agents (2018-2023)

    16. Combination Hemostats Market for Hemostatic Agents (2018-2023)

    17. Fibrin Sealants Market for Hemostatic Agents (2018-2023)

Does IndustryARC customize these reports and charge additionally for limited customization?

Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:

      1. Increase the level of data in application or end user industry.
      2. Increase the number of countries in geography chapter.
      3. Find out market shares for other smaller companies or companies which are of interest to you.
      4. Company profiles can be requested based on your interest.
      5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.

Any other major customizations can be discussed with our team, we can provide a separate quote based on your requirement. You can drop in an e-mail to sales@industryarc.com to discuss more about our consulting services.

To request for a proposal provide your details in the below link:


Media Contact:
Mr. Venkat Reddy
Sales Manager
Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC:

IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences &Healthcare.

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications in a Market. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business.

We look forward to support the client to be able to better address their customer needs, stay ahead in the market, become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.


Go to website

Also Read:  Reliance Infosystems announces partnership with RackNap to drive Microsoft cloud adoption in Africa